• Newsletter
  • Contact
  • Press Releases
Friday, June 6, 2025
Stay Ahead with Heaptalk: Your Go-To Source for Business News
  • Login
  • Register
  • Whats on
  • News
  • Events
  • Technology
  • Industry
  • GovAct
  • Expert Talk
  • Insight
  • Sustainability
No Result
View All Result
Stay Ahead with Heaptalk: Your Go-To Source for Business News
  • Whats on
  • News
  • Events
  • Technology
  • Industry
  • GovAct
  • Expert Talk
  • Insight
  • Sustainability
No Result
View All Result
Stay Ahead with Heaptalk: Your Go-To Source for Business News
No Result
View All Result
Home News

Pneumococcal Conjugate Vaccine (PCV), Indonesia’s Vaccine Across The Country

Wulan by Wulan
August 2, 2023
in News
0
vaccine-pcv

Indonesia Introduces Pneumococcal Conjugate Vaccine (Pcv) Across The Country

Share on FacebookShare on Twitter

 Heaptalk, Jakarta/Geneva  – Up to 4.5 million children across Indonesia will be protected against the most common cause of severe pneumonia every year after introducing Pneumococcal Conjugate Vaccine (PCV) (2/07) into the country’s routine immunization program.

Almost half a million children are currently at risk of dying from pneumonia each year in Indonesia, with 10,000 deaths caused by the pneumococcus bacteria annually. While the vaccine has been available in certain areas of the country, this nationwide introduction, led by the Government of Indonesia with support from Gavi the Vaccine Alliance, UNICEF, the Bill and Melinda Gates Foundation, and partners, means every child in the country will now be able to access the vaccine free of charge.

“Increasing access to the PCV will ensure all Indonesia’s children will be protected, no matter where they live,” said Anuradha Gupta, Deputy Chief Executive Officer of Gavi, the Vaccine Alliance. “Congratulations to the Government of Indonesia on this milestone, which will save the lives of thousands of children across the country for years to come.”

World Ai Jakarta 2025
World Ai Jakarta 2025

The introduction of the PCV vaccine will be carried out in stages across targeted regions, and by 2022 it will be expanded nationwide. Three doses of the vaccine will be given to children at the age of two, three, and 12 months.

“The COVID-19 pandemic has raised the profile of vaccines as one of the best tools we have to fight the threat of disease. It has also driven home our awareness of the social and economic impacts of uncontrolled outbreaks of controllable diseases,” said Henrietta Fore, UNICEF Executive Director.

“At UNICEF, we know this well from decades of experience with routine childhood vaccinations. That’s why we know that accelerating and expanding the reach of the PCV vaccine across Indonesia will protect children against a major health threat and bring with it social and economic benefits. The government of Indonesia is to be commended for their leadership in this effort.”

The Government of Indonesihasve procured the first 1.6 million doses of the vaccine through the Gavi Pneumococcal Advanced Market Commitment mechanisms pioneered in 2009 by Gavi, the Vaccine Alliance as an innovative instrument to drive access to safe, affordable vaccines in low- and middle-income countries. More than 60 of the 73 Gavi-eligible countries have now introduced PCV, protecting over 183 million children. Further introductions are planned for 2021 and 2022.

The introduction of the PCV vaccine comes as COVID-19 threatens to roll back hard-earned gains across many childhood routine immunization programs. Thanks to the leadership of the Government of Indonesia, Gavi, UNICEF, and partners continue to work together to mitigate the devastating effects of the pandemic to ensure that children receive the life-saving vaccinations they need.

“The rollout of the pneumococcal conjugate vaccine is a critical step toward protecting children in Indonesia from pneumonia. We congratulate the Government of Indonesia and its partners on this momentous achievement to prevent this life-threatening disease and ensure all children reach their full potential,” said Chris Elias, President of the Global Development Division at the Bill & Melinda Gates Foundation.

The PCV Immunisation Demonstration Program was implemented in Indonesia in 2017 – 2019 in the West Nusa Tenggara and Bangka Belitung Provinces. The demonstration program results showed that the PCV immunization coverage during that period was above 80% on average, indicating that the community well-received these vaccines.

 

About Gavi, the Vaccine Alliance

Gavi, the Vaccine Alliance, is a public-private partnership that helps vaccinate half the world’s children against some of the world’s deadliest diseases. Since its inception in 2000, Gavi has helped to immunize a whole generation – over 822 million children – and prevented more than 14 million deaths, helping to halve child mortality in 73 lower-income countries. Gavi also plays a key role in improving global health security by supporting health systems and funding global stockpiles for Ebola, cholera, meningitis, and yellow fever vaccines. After two decades of progress, Gavi is now focused on protecting the next generation and reaching the unvaccinated children still being left behind, employing innovative finance and the latest technology – from drones to biometrics – to save millions of more lives, prevent outbreaks before they can spread and help countries on the road to self-sufficiency.

The Vaccine Alliance brings together developing country and donor governments, the World Health Organization, UNICEF, the World Bank, the vaccine industry, technical agencies, civil society, the Bill & Melinda Gates Foundation, and other private sector partners.

Tags: bill and melinda gates foundationcovid19gavivaccine

Related Posts

Paving the Way for Expatriate Homeownership: Savyavasa and Permata Bank Launch Exclusive Foreign Mortgage Program

Paving the Way for Expatriate Homeownership: Savyavasa and Permata Bank Launch Exclusive Foreign Mortgage Program

June 5, 2025
KL1 Phase 2 has been completed. Credit: Equinix

Equinix completes KL1 Phase 2 data center in Kuala Lumpur

June 2, 2025
Commemorating Professor Soemitro's 108th anniversary at Soemitro Center (05/29). Credit: Haris

Soemitro Center: A platform for Indonesia’s young economists

May 31, 2025
Lifree breathable adult diapers can help improve skin health. Credit: Haris

Unicharm research: Lifree improves quality of life for elderly

May 31, 2025
Xiaomi's premiumization strategy has yielded positive results in Q1 2025. Credit: Sinta

Applying premiumization strategy, Xiaomi gains 64.5% net profit jump in Q1 2025

May 31, 2025
Kaspersky appointed Defi Nofitra as first country manager for Indonesia. Credit: Kaspersky

Kaspersky appoints Defi Nofitra as first country manager for Indonesia

May 31, 2025
  • 32321

    New tech layoff chapter, Microsoft lays off thousands of its cloud unit ‘Azure’

    1 shares
    Share 0 Tweet 0
  • Nokia rolls out 6600 5G Ultra

    0 shares
    Share 0 Tweet 0
  • Performing a second layoff round, Morgan Stanley to reduce 3,000 workforces in Q2 2023

    1 shares
    Share 0 Tweet 0
  • TikTok Shop to reach a US$15 billion in its GMV transactions

    1 shares
    Share 0 Tweet 0
  • International Women’s Day – Opportunity for Businesses to Support Women in the Workplace

    0 shares
    Share 0 Tweet 0
the 10th world battery & energy industry expo 2025World Ai Jakarta 2025
Heaptalk business news logo

We Build an Ecosystem by Sharing Business News, Headlines and Expert Talks in Professional Perspective and Positive Point of View. Latest business news media headlines platform today.

Recent Posts

  • Paving the Way for Expatriate Homeownership: Savyavasa and Permata Bank Launch Exclusive Foreign Mortgage Program
  • Equinix completes KL1 Phase 2 data center in Kuala Lumpur
  • Soemitro Center: A platform for Indonesia’s young economists
  • Unicharm research: Lifree improves quality of life for elderly
  • Applying premiumization strategy, Xiaomi gains 64.5% net profit jump in Q1 2025

Follow Us

Facebook
Twitter
LinkedIn Youtube Instagram RSS

Newsletter

  • About Us
  • Editorial
  • Newsletter
  • Contact
  • Privacy Policy
  • Cyber Media Guidelines
  • Disclaimer
  • SOP Perlindungan Wartawan

Welcome Back!

Login to your account below

Forgotten Password? Sign Up

Create New Account!

Fill the forms below to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Do not sell my personal information.
Cookie settingsACCEPT
Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT
No Result
View All Result
  • Home
  • News
  • Technology
  • Industry
  • GovAct
  • Events
  • Whats on
  • Expert Talk
  • Insight
  • Sustainability
  • Newsletter
  • Press Releases
  • Login
  • Sign Up

© 2024 Heaptalk.com